Using Urinary Biomarkers to Reduce Acute Kidney Injury Following Cardiac Surgery
The routine measurement of UB and subsequent activation of an AKRT are useful post–cardiac surgery therapeutic adjuncts.
You may also like
Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19
For now—and possibly the next 18 to 24 months, convalescent plasma, despite supply issues and questions about efficacy and who is most likely to benefit from treatment, remains the only off-the-shelf therapy for COVID-19.
1 min read
Gearing Up for Sanibel Symposium 2026: Meet Keynote Speaker Dr. Richard “Harry” Harris
The Sanibel Symposium continues to bring together the brightest minds in perfusion. And in May 2026, attendees will hear from one of the most extraordinary […]
1 min read